Opexa Therapeutics Inc. (NASDAQ: OPXA | Quote | Chart | News | PowerRating) a development stage biopharmaceutical company, develops autologous cellular therapies for the treatment of multiple sclerosis, rheumatoid arthritis, and diabetics. Its therapies are based on the company's T-cell and adult stem cell technologies. The company's products include Tovaxin, a T-cell therapeutic vaccine that is in Phase IIb clinical trial for the treatment of multiple sclerosis. Its Rheumatoid Arthritis T-cell vaccination technology, which is in preclinical development stage allows the isolation of pathogenic T-cells from synovial fluid drawn from a patient; as well as Adult Stem Cell technology that is in preclinical development stage is used to treat diabetes; and is in research and development stage to treat heart failure. The company was founded in 2003. It was formerly known as PharmaFrontiers Corp. and changed its name to Opexa Therapeutics, Inc. in 2006. Opexa Therapeutics is based in the Woodlands, Texas. With 12.26 million shares outstanding and 3,600 shares declared short as of September 2008, there is a failure to deliver in shares of OPXA. According to quarterly data provided by the SEC, there were still 203,705 shares of OPXA that were failing-to-deliver as of February 25, 2008.
Advanced Viral Research Corp. (OTCBB: ADVR | Quote | Chart | News | PowerRating) a biopharmaceutical company, engages in the research, development, and commercialization of small molecule therapeutics that address medical needs for various degenerative conditions in the United States. Its products include AVR118, a cytoprotective drug composed of a complex mixture of protein and ribonucleic acid components; AVR123, a form of AVR118 specially designed for dermatology applications, which is in Phase II clinical trials; AVR147, an inhibitor of a cancer target known as a proteasome; AVR168 that is a natural product, which inhibits a member of a family of motor proteins that are responsible for the assembly and function of microtubules during cell division. The company develops its products focusing on the treatment of systemic symptoms, such as cachexia (body wasting), loss of appetite and lethargy experienced by patients with advanced malignant cancer, HIV-AIDS, cardiovascular disease, sepsis, viral infections, and other diseases, as well as to treat as an aid in wound healing. Its also develops its products for use as an anti-inflammatory in conditions, such as rheumatoid arthritis; and palliative agent to minimize certain toxicities associated with chemo or immunotherapies. The company was founded in 1984 and is based in Yonkers, New York. With 846.23 million shares outstanding and 913,300 shares declared short as of September 2008, there is a failure to deliver in shares of ADVR. According to quarterly data provided by the SEC, there were still 8,454,142 shares of ADVR that were failing-to-deliver as of April 4, 2008.
Xinhua China Ltd. (OTCBB: XHUA | Quote | Chart | News | PowerRating) operates as a co-publishing and digital media company. It engages in Internet book distribution business. The company is based in Beijing, the People's Republic of China. With 54.64 million shares outstanding and 1,200 shares declared short as of September 2008, there is a failure to deliver in shares of XHUA. According to quarterly data provided by the SEC, there were still 10,208,646 shares of XHUA that were failing-to-deliver as of April 18, 2008.
Poseidis Inc. (OTC: PSED | Quote | Chart | News | PowerRating) a development stage company, together with its subsidiary Montespan SAS, engages in the development of a sparkling mineral water spring in central France known as the La Troliere Spring. The company intends to develop and market a new brand of sparkling natural mineral water under the brand name l' Eau de Montespan', as well as other beverage products utilizing the mineral water drawn from the La Troliere Spring. It would sell these products in France, Canada, the United Kingdom, Italy, Spain, Germany, and the United States. Poseidis is based in West Palm Beach, Florida. With 135.51 million shares outstanding and 12,300 shares declared short as of September 2008, there is a failure to deliver in shares of PSED. According to quarterly data provided by the SEC, there were still 400,234 shares of PSED that were failing-to-deliver as of October 11, 2007.
New World Dev Ltd Ord (OTC: NDVLY | Quote | Chart | News | PowerRating) together with its subsidiaries, engages in the property and hotel, infrastructure and service, and department store businesses in Hong Kong, southeast Asia, Macau, and the People's Republic of China. Its property portfolio comprises shopping malls, offices, hotels, service apartments, residential complexes, villas, and multi-use high-rise commercial buildings. The company's infrastructure business involves the operation of projects primarily in the energy, roads, water, and ports segments; and service business provides facilities rental, contracting, and transport services. The company operates 29 department stores in Hong Kong, as well as in 15 cities in Mainland China, including Wuhan, Shenyang, Wuxi, Harbin, Tianjin, Ningbo, Beijing, Shanghai, Dalian, Kunming, and Lanzhou. In addition, New World Development Company provides a portfolio of voice, data, and content services; involves in industrial manufacturing, consumer goods production, production management, and retail distribution chain stores businesses. The company was founded in 1970 and is based in Central, Hong Kong. With 1.88 billion shares outstanding and 19,200 shares declared short as of September 2008, there is a failure to deliver in shares of NDVLY. According to quarterly data provided by the SEC, there were still 1,664,662 shares of NDVLY that were failing-to-deliver as of June 16, 2008.
WCI Communities Inc (OTC: WCIMQ | Quote | Chart | News | PowerRating) operates as an integrated homebuilding and real estate services company in the United States. Its activities include single and multi-family homebuilding and mid and high-rise homebuilding, as well as the provision of real estate services. The company designs, sells, and builds traditional homes serving primary, second, and retirement home buyers; and designs, builds, and sells luxury residential towers and condominium hotels targeted to primary and affluent, leisure-oriented home purchasers. It also offers real estate services, including realty brokerage, title insurance and closing services, and mortgage banking services. In addition, the company develops and operates amenity facilities, including championship golf courses with clubhouses, fitness, tennis and recreational facilities, guest lodging, marinas, and restaurants; and sells selected land parcels to other builders and to end users for the design and construction of homes, as well as enters into real estate joint ventures. As of December 31, 2007, it had 79 locations where it builds single-family and multi-family homes or mid-rise and high-rise residential units, or operating amenity facilities. The company was founded in 1946 and is headquartered in Bonita Springs, Florida. On August 4, 2008, WCI Communities Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Wilmington. With 42.17 million shares outstanding and 9.12 million shares declared short as of September 2008, there is a failure to deliver in shares of WCIMQ.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,200,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index